石榴 Pomegranate × 心血管疾病
All cardiovascular evidence for pomegranate rests on surrogate markers, with no trial reporting hard outcomes (myocardial infarction, stroke, cardiovascular mortality).
All cardiovascular evidence for pomegranate rests on surrogate markers, with no trial reporting hard outcomes (myocardial infarction, stroke, cardiovascular mortality). The strongest signal is blood-pressure reduction: two meta-analyses (8 and 22 RCTs) consistently show SBP falling roughly 5-8 mmHg, but both carry very high statistical heterogeneity (I-squared near 90%) and largely undisclosed funding, so industry conflict of interest cannot be excluded. Crucially, the only adequately powered randomised controlled trial of carotid intima-media thickness (PMID 19766760, n=289, 18 months) was NEGATIVE on its primary endpoint, with benefit appearing only in post-hoc exploratory subgroups, and the widely cited 30%-CIMT-reduction study (PMID 15158307) is n=10, non-randomised and unblinded - low quality with high bias risk. A 12-RCT lipid meta-analysis found no significant effect on cholesterol or triglycerides, and EFSA rejected every pomegranate cardiovascular-related health claim while FDA issued a warning letter against exactly these atherosclerosis and blood-pressure claims. The totality is genuine but small, inconsistent and surrogate-only evidence with a failed pivotal hard-ish endpoint - a clear C, not B.
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.472
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 positive (3 篇 > 1 negative)
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
台灣 PTT/Dcard/Mobile01 對石榴（紅石榴）的真實討論幾乎全部集中在美容養顏（美白、抗老、膠原蛋白飲搭配成分）、豐胸複方、補鐵配方，以及果汁口味試飲；另有大量『石榴石/紅石榴石水晶』同名雜訊。完全找不到鄉民『為了心血管疾病而吃石榴並回報實際感受』的親身心得。心血管訴求（護血管、降膽固醇、抑制 ACE 降血壓、抗動脈硬化）幾乎只出現在受業配/affiliate 污染的商業健康媒體（早安健康、Heho、康健、健康醫學院）與偽裝成『PTT/Dcard 網友推薦排行榜』的導購懶人包（PureStyle、Topicksnow 等），這些文章列舉功效卻無任何真實使用者經驗。就『心血管疾病』此 condition 而言，社群層面屬冷門無實質討論。
無共識（社群幾乎不以心血管為由討論石榴；真實心得集中在美容養顏、皮膚保養與果汁口味，無人回報心血管實際效果）
依論壇被提及頻率，非銷售或品質排序。
- POM Wonderful（社群提到的純石榴汁代表）
- BOTO（韓系石榴汁，討論度高）
- 正官庄（韓系石榴飲）
- Biotta（有機石榴汁）
- SSF 紅石榴美顏飲（美容導向）
⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。
- 生活型態優化（健康飲食、身體活動、戒菸）
- 史他汀類藥物（適應症族群）
- 戒菸（行為介入合併藥物）
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-cardiovascular-disease-INT-pomegranate-001/",
"datePublished": "2026-06-01",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "石榴能改善心血管疾病",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 2,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🟠 C 薄弱證據"
}
}